MH:NYSEMcGraw Hill, Inc. Analysis
Data as of 2026-04-17 - not real-time
$13.96
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
McGraw Hill (MH) trades at $13.96, comfortably above its 20‑day SMA ($13.59) but still below the 200‑day SMA ($14.31), indicating a short‑term bounce within a longer‑term downtrend. The MACD histogram is positive and the signal line is bullish, while RSI sits at a neutral 54, suggesting modest upside momentum toward the $14.38 resistance. Fundamentally, the company boasts an impressive 80.8% gross margin and positive free cash flow, yet it posted a -3.4% profit margin and carries a staggering $2.7 B debt load (Debt/Equity > 300%). The DCF fair value of $32.71 implies a 46% upside, reinforced by analyst targets near $19‑$20 and a “strong_buy” consensus. Market sentiment is extremely bullish (Fear‑Greed Index 89), but volume is declining, adding liquidity caution. Overall, the stock appears deeply undervalued with strong growth catalysts, but high leverage and volatility temper the risk profile.
Investors should weigh the defensive nature of the education sector against regulatory exposure and the company’s debt burden. The forward PE of 8× and positive forward EPS point to earnings recovery, while the lack of dividend underscores reliance on capital appreciation. Given the mix of technical bullishness, substantial upside potential, and financial leverage, a cautiously optimistic stance is warranted.
Investors should weigh the defensive nature of the education sector against regulatory exposure and the company’s debt burden. The forward PE of 8× and positive forward EPS point to earnings recovery, while the lack of dividend underscores reliance on capital appreciation. Given the mix of technical bullishness, substantial upside potential, and financial leverage, a cautiously optimistic stance is warranted.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD histogram and price above 20‑day SMA
- Support level at $12.86 provides downside cushion
- Decreasing volume raises short‑term liquidity concerns
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward EPS turning positive and forward PE of 8×
- Analyst price targets around $19‑$20 indicating 30‑40% upside
- Strong gross margins and positive free cash flow supporting earnings growth
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- DCF fair value of $32.71 suggests >40% long‑term upside
- Expanding digital education footprint internationally
- Defensive education sector demand offsets regulatory and debt risks over time
Key Metrics & Analysis
Financial Health
Revenue Growth4.20%
Profit Margin-3.37%
P/E Ratio8.0
ROE-11.76%
ROA3.54%
Debt/Equity348.34
P/B Ratio3.4
Op. Cash Flow$436.1M
Free Cash Flow$519.5M
Technical Analysis
TrendNeutral
RSI54.2
Support$12.86
Resistance$14.38
MA 20$13.59
MA 50$13.56
MA 200$14.31
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39
Valuation
Fair Value$32.71
Target Price$20.42
Upside/Downside46.25%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.78
Volatility33.86%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.